Stockscreener 앱 받기
26.42
6.49%
1.61
Immunovant Inc 주식(IMVT)의 최신 뉴스
EPS Watch: Why OrthoPediatrics Corp. stock appeals to dividend seekersWeekly Stock Report & Low Drawdown Trading Strategies - moha.gov.vn
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m - Investing.com
Immunovant Raises $550 Million Through Stock Offering - TipRanks
Immunovant: 'Buy' On Competitive Batoclimab Landscape And IMVT-1402 Advancement - Seeking Alpha
Immunovant Enters Underwriting Agreement for Stock Offering - TradingView — Track All Markets
Immunovant (NASDAQ:IMVT) Stock Price Up 8.1%Here's Why - MarketBeat
Immunovant, Inc. $IMVT is Armistice Capital LLC's 9th Largest Position - MarketBeat
Immunovant drops 7%, prices $550M stock offering - MSN
Immunovant announces $550 million stock offering - MSN
Latham & Watkins Advises on Immunovant’s US$550 Million Offering of Common Stock - Latham & Watkins LLP
Immunovant announces $550 million stock offering and clinical program updates - Investing.com Canada
HighVista Strategies LLC Buys 87,160 Shares of Immunovant, Inc. $IMVT - MarketBeat
Immunovant announces $550 million stock offering and clinical program updates By Investing.com - Investing.com South Africa
Immunovant Announces $550 Million Stock Offering - TipRanks
Immunovant announces pricing of $550 million common stock financing - marketscreener.com
Immunovant Announces Pricing Of $550 Million Common Stock Financing - TradingView — Track All Markets
Immunovant Prices $550 Million Stock Offering - marketscreener.com
Immunovant Announces Pricing of $550 Million Common Stock Financing - The Globe and Mail
Immunovant (Nasdaq: IMVT) raises $550M to support potential IMVT-1402 Graves’ launch - Stock Titan
Immunovant (IMVT) Down 0.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Immunovant, Inc. $IMVT Shares Purchased by Jump Financial LLC - MarketBeat
Norges Bank Buys Shares of 687,662 Immunovant, Inc. $IMVT - MarketBeat
55,524 Shares in Immunovant, Inc. $IMVT Purchased by Capital Fund Management S.A. - MarketBeat
Two Seas Capital LP Boosts Stake in Immunovant, Inc. $IMVT - MarketBeat
Insider Selling: Immunovant (NASDAQ:IMVT) Director Sells 15,000 Shares of Stock - MarketBeat
Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Insider Selling: Immunovant (NASDAQ:IMVT) Director Sells 22,249 Shares of Stock - MarketBeat
Immunovant Executives Sell Shares Under Trading Plans - TradingView
Dir Fromkin Surrenders 22,249 Of Immunovant Inc [IMVT] - TradingView
Is Immunovant (IMVT) Overvalued? Taking Stock of Its Premium Price-to-Book Multiple - Yahoo Finance
Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings - MSN
Immunovant (IMVT) Stock Analysis Report | Financials & Insights - Benzinga
XTX Topco Ltd Buys New Holdings in Immunovant, Inc. $IMVT - MarketBeat
Tejara Capital Ltd Raises Position in Immunovant, Inc. $IMVT - MarketBeat
Immunovant, Inc. $IMVT Shares Acquired by Geode Capital Management LLC - MarketBeat
(IMVT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
12 Best Short Squeeze Stocks to Buy Right Now - Insider Monkey
Immunovant’s Earnings Call Highlights Clinical Success and Financial Strength - MSN
Officer Geffner Files To Sell 50,000 Of Immunovant Inc [IMVT] - TradingView
Officer Geffner Files To Sell 103,897 Of Immunovant Inc [IMVT] - TradingView
Immunovant (IMVT): Assessing Valuation Following R&D Leadership Restructuring and CMO Departure - Sahm
JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN
Have Insiders Sold Immunovant Shares Recently? - simplywall.st
Immunovant Restructures R&D Leadership with CMO Departure - The Globe and Mail
Immunovant COO Gloria sells $298k in shares By Investing.com - Investing.com Nigeria
Immunovant COO Gloria sells $298k in shares - Investing.com
Immunovant Insider Sold Shares Worth $298,237, According to a Recent SEC Filing - MarketScreener
Immunovant COO Gloria Melanie Sells Shares to Cover Tax Obligations - TradingView
[Form 4] Immunovant, Inc. Insider Trading Activity - Stock Titan
[8-K] Immunovant, Inc. Reports Material Event | IMVT SEC FilingForm 8-K - Stock Titan
Immunovant, Inc. Announces Cessation of Michael Geffner, M.D., M.B.A. as Chief Medical Officer, Effective November 21, 2025 - marketscreener.com
How analysts rate Immunovant Inc. stock todayInsider Selling & Technical Entry and Exit Tips - newser.com
Will Immunovant Inc. stock outperform value stocksTrade Exit Summary & Weekly Breakout Watchlists - newser.com
Is Immunovant Inc. stock affected by interest rate hikesJuly 2025 Gainers & Stepwise Trade Signal Implementation - newser.com
Can swing trading help recover from Immunovant Inc. losses2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
1.08%
0.91%
자본화:
|
볼륨(24시간):